Mona Ahmed Elhabak

Dr. Mona Ahmed Elhabak


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MEMona Ahmed Elhabak
Mona Ahmed Elhabak
ASAbeer A.A. Salama
Abeer A.A. Salama
ASAlaa H. Salama
Alaa H. Salama

6 March 2019 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
SMSamah Abdelsabour Mohammed
Samah Abdelsabour Mohammed
MEMona Ahmed Elhabak
Mona Ahmed Elhabak
MEMohammed Eldardiri
Mohammed Eldardiri
A simple, rapid and fully-validated liquid chromatographic method (RP HPLC) with fluorescence detection was developed for the analysis of rhein (as the main metabolite of diacerein) in human plasma. The separation was performed using an ODS C18 column with mobile phase acetonitrile: methanol: phosphate buffer pH 6.8 and the flow rate was1.0 mL/min. The fluoremetric detection was performed at 2 excitation wavelengths ʎex= 440 nm & 338 nm and one emission wavelength at ʎ em = 520 nm . The developed method was validated according to Food and Drug Adminstration (FDA) guideline for bioanalytical method validation. The pharmacokinetic parameters of the test and reference were determined and the analysis of variance (ANOVA) between parameters of the two brands were calculated. The relative bioavailability was found to be 89%. This method was successfully applied to the routine bioequivalence analysis of diacerein in plasma.